Aeon Medix Inc.
Records under this name other than patents Aeon Medix Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 8 of 8 · Back to Aeon Medix Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,969,653 | Extracellular Vesicles Derived from Gram-Positive Bacteria, and Use Thereof Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,084,830 | Microvesicles Derived from Cell Protoplast and Use Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,149,542 | Microvesicles Derived from Cell Protoplast and Use Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 8,030,274 | Method for treating asthma and chronic obstructive pulmonary disease (COPD) comprising administering FGF2 Formerly held Term ended Term ended Jul 20, 2026 · From the USPTO record | Term ended | Term ended Jul 20, 2026 | From the USPTO record |
| US 8,691,522 | Composition comprising extracellular membrane vesicles derived from indoor air, and use thereof Lapsed on the fee record Ended Apr 8, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 8, 2026 | From the USPTO record |
| US 9,273,359 | Extracellular vesicles derived from Gram-positive bacteria, and use thereof Lapsed on the fee record Ended Mar 1, 2024 · From the USPTO record | Lapsed on the fee record | Ended Mar 1, 2024 | From the USPTO record |
| US 9,274,109 | Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using the same Lapsed on the fee record Ended Mar 1, 2024 · From the USPTO record | Lapsed on the fee record | Ended Mar 1, 2024 | From the USPTO record |
| US 9,201,072 | Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using the same Lapsed on the fee record Ended Dec 1, 2023 · From the USPTO record | Lapsed on the fee record | Ended Dec 1, 2023 | From the USPTO record |